Phibro Animal Health (NASDAQ:PAHC) Sees Unusually-High Trading Volume – Still a Buy?

Shares of Phibro Animal Health Co. (NASDAQ:PAHC) saw unusually-strong trading volume on Wednesday . Approximately 326,135 shares traded hands during mid-day trading, an increase of 112% from the previous session’s volume of 153,695 shares.The stock last traded at $21.66 and had previously closed at $20.68.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. Morgan Stanley raised their price objective on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 17th. Barclays raised their target price on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a report on Tuesday, November 12th. Finally, StockNews.com raised Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, January 4th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $20.50.

Phibro Animal Health Stock Performance

The firm’s 50-day moving average price is $22.75 and its two-hundred day moving average price is $21.08. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81. The firm has a market capitalization of $812.09 million, a PE ratio of 46.63, a P/E/G ratio of 0.58 and a beta of 0.53.

Phibro Animal Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th were given a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.39%. The ex-dividend date of this dividend was Wednesday, November 27th. Phibro Animal Health’s dividend payout ratio (DPR) is 111.63%.

Hedge Funds Weigh In On Phibro Animal Health

Hedge funds have recently modified their holdings of the stock. Sofinnova Investments Inc. purchased a new position in Phibro Animal Health in the second quarter valued at about $3,975,000. Geode Capital Management LLC grew its stake in shares of Phibro Animal Health by 5.7% in the 3rd quarter. Geode Capital Management LLC now owns 507,469 shares of the company’s stock valued at $11,430,000 after buying an additional 27,201 shares in the last quarter. Barclays PLC grew its stake in shares of Phibro Animal Health by 25.7% in the 3rd quarter. Barclays PLC now owns 143,337 shares of the company’s stock valued at $3,228,000 after buying an additional 29,271 shares in the last quarter. Algert Global LLC increased its holdings in Phibro Animal Health by 521.1% in the third quarter. Algert Global LLC now owns 71,335 shares of the company’s stock worth $1,606,000 after buying an additional 59,850 shares during the last quarter. Finally, BNP Paribas Financial Markets raised its position in Phibro Animal Health by 3.1% during the third quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock valued at $548,000 after acquiring an additional 729 shares in the last quarter. 99.34% of the stock is owned by institutional investors and hedge funds.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.